Acoramidis
Acoramidis is currently under laboratory validation and pilot process optimization for TTR Stabilizer therapy.
Acoramidis is currently under laboratory validation and pilot process optimization for TTR Stabilizer therapy.
Resmetirom is currently under laboratory validation and pilot process optimization for Thyroid Hormone Receptor (THR) agonist therapy.